Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Klinggruppen Promera AB
AB
Active
Org 5594633488
Energivägen 2 C
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
10-19 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
—
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
—
—
Net profit
—
—
Total assets
SEK 50K
—
Equity
SEK 50K
—
Employees
—
—
Company information
Legal name
Klinggruppen Promera AB
Org number
5594633488
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 december 2023
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Kling, Bo Fredrik Kling, Sekina
Company purpose
Bolaget ska bedriva utveckling och försäljning av produkter och tjänster inom hälsa och därmed förenlig verksamhet.
Contact
Address
Energivägen 2 C
Email
fredrik.kling@klinggruppen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Nacka
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
—
EBITDA
—
Depreciation & amort.
—
EBIT
0
Net financials
—
Profit before tax
0
Tax
—
Net profit
—
Balance sheet
SEK thousands
Item
2024
Total assets
50
Equity
50
Long-term debt
—
Short-term debt
—
Total debt
—
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2024
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2024
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2024
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-12-15 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
LJ
Leo Johannes Zoffmann-Petersen
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2025
BF
Bo Fredrik Kling
Chief Executive Officer
Chief Executive Officer
2025
Former (1)
JU
Josephine Ulfsparre Mohaupt
Chief Executive Officer
Chief Executive Officer
2023 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SK
Sekina Kling
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Klinggruppen Promera AB also hold positions in
0
other companies.
Person
Role here
Other companies
Josephine Ulfsparre Mohaupt
Chief Executive Officer
0 companies
Leo Johannes Zoffmann-Petersen
Deputy Chief Executive Officer
0 companies
Bo Fredrik Kling
Chief Executive Officer
0 companies
Sekina Kling
Chairman
0 companies